Kana Miyazaki

15PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 12, 2026
Emerging treatment strategies for newly diagnosed diffuse large B-cell lymphoma.

|Apr 25, 2026
Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma.

|Apr 09, 2026
Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients.

Kazutaka Suzuki, Kana Miyazaki, Naoko Asano

|Dec 16, 2025
Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER).

Yusuke Sano, Kana Miyazaki, Motoko Yamaguchi

|Sep 02, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Ken Ohmachi, Tomohiro Kinoshita, Dai Maruyama

|Feb 17, 2025
Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study.

Ayumi Fujimoto, Kana Miyazaki, Kimikazu Yakushijin

Pageof 3

Frequent Collaborators

6 joint publications

Dai Maruyama

5 joint publications

Motoko Yamaguchi

3 joint publications

Kazuhito Yamamoto

3 joint publications

Wataru Munakata